23-valent Pneumococcal Polysaccharide Vaccine - WHO Position Paper
This report, published in the Weekly Epidemiological Record, provides essential background information on pneumococcal disease and gives the current World Health Organization position concerning the use of the 23-valent pneumococcal polysaccharide vaccine in the global context.
Author(s): World Health Organization
Download file (English, French)
Also known as: Vaccin antipneumococcique polyosidique 23-valent - Note de synthèse de l’OMS
315 KB PDF (Located at www.who.int)